KCNQ4 and breast carcinoma: The EdU proliferation assay, the results revealed that breast cancer cells MDA-MB-231(Fig. 14C) and MDA-MB-468 (Fig. 14E) with overexpressed KCNQ4 plasmid exhibited significantly reduced proliferation rates compared to the control group.